Literature DB >> 29344123

Ex vivo model of non-small cell lung cancer using mouse lung epithelial cells.

Taku Sato1,2,3, Mami Morita1, Ryota Tanaka1,2,3, Yui Inoue1, Miyuki Nomura1, Yoshimi Sakamoto1, Koh Miura4, Shigemi Ito1, Ikuro Sato5, Nobuyuki Tanaka6, Jiro Abe2, Satomi Takahashi2, Masaaki Kawai7, Masami Sato8, Yoshitaka Hippo9, Hiroshi Shima1,10, Yoshinori Okada3, Nobuhiro Tanuma1,10.   

Abstract

Lung cancer is the most common cause of cancer mortality, however, efficient methods to culture, expand and transform lung epithelial (LE) cells have not been established. In the present study, an efficient ex vivo method was applied to recapitulate lung carcinogenesis using mouse LE cells. A Matrigel-assisted three-dimensional culture was used to isolate and selectively expand LE cells from mouse lungs. Purified LE cells were passaged and expanded for at least 2 to 3 months while maintaining epidermal growth factor-dependence. LE cells were also easily transformed by genetic manipulations using retroviral vectors. A SV40 large-T antigen, suppressing p53 and pRB, plus an activated oncogene, such as KrasG12V or EGFRex19del, were required to transform LE cells. Transformed cells formed tumors resembling non-small cell lung cancer (NSCLC) in allograft models and exhibited strong oncogene addiction. This experimental system provided a unique model system to study lung tumorigenesis and develop novel therapeutics against NSCLC.

Entities:  

Keywords:  EGFR; Kras; lung cancer; non-small cell lung cancer; tumorigenesis

Year:  2017        PMID: 29344123      PMCID: PMC5754888          DOI: 10.3892/ol.2017.7098

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  24 in total

1.  Plat-E: an efficient and stable system for transient packaging of retroviruses.

Authors:  S Morita; T Kojima; T Kitamura
Journal:  Gene Ther       Date:  2000-06       Impact factor: 5.250

2.  Enumeration of the simian virus 40 early region elements necessary for human cell transformation.

Authors:  William C Hahn; Scott K Dessain; Mary W Brooks; Jessie E King; Brian Elenbaas; David M Sabatini; James A DeCaprio; Robert A Weinberg
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

Review 3.  Nivolumab in NSCLC: latest evidence and clinical potential.

Authors:  Raghav Sundar; Byoung-Chul Cho; Julie R Brahmer; Ross A Soo
Journal:  Ther Adv Med Oncol       Date:  2015-03       Impact factor: 8.168

4.  Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.

Authors:  Makoto Maemondo; Akira Inoue; Kunihiko Kobayashi; Shunichi Sugawara; Satoshi Oizumi; Hiroshi Isobe; Akihiko Gemma; Masao Harada; Hirohisa Yoshizawa; Ichiro Kinoshita; Yuka Fujita; Shoji Okinaga; Haruto Hirano; Kozo Yoshimori; Toshiyuki Harada; Takashi Ogura; Masahiro Ando; Hitoshi Miyazawa; Tomoaki Tanaka; Yasuo Saijo; Koichi Hagiwara; Satoshi Morita; Toshihiro Nukiwa
Journal:  N Engl J Med       Date:  2010-06-24       Impact factor: 91.245

5.  Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors.

Authors:  Esra A Akbay; Shohei Koyama; Julian Carretero; Abigail Altabef; Jeremy H Tchaicha; Camilla L Christensen; Oliver R Mikse; Andrew D Cherniack; Ellen M Beauchamp; Trevor J Pugh; Matthew D Wilkerson; Peter E Fecci; Mohit Butaney; Jacob B Reibel; Margaret Soucheray; Travis J Cohoon; Pasi A Janne; Matthew Meyerson; D Neil Hayes; Geoffrey I Shapiro; Takeshi Shimamura; Lynette M Sholl; Scott J Rodig; Gordon J Freeman; Peter S Hammerman; Glenn Dranoff; Kwok-Kin Wong
Journal:  Cancer Discov       Date:  2013-09-27       Impact factor: 39.397

Review 6.  Regulation of MAPKs by growth factors and receptor tyrosine kinases.

Authors:  Menachem Katz; Ido Amit; Yosef Yarden
Journal:  Biochim Biophys Acta       Date:  2007-01-10

7.  Rare codons regulate KRas oncogenesis.

Authors:  Benjamin L Lampson; Nicole L K Pershing; Joseph A Prinz; Joshua R Lacsina; William F Marzluff; Christopher V Nicchitta; David M MacAlpine; Christopher M Counter
Journal:  Curr Biol       Date:  2012-12-13       Impact factor: 10.834

Review 8.  Modeling Development and Disease with Organoids.

Authors:  Hans Clevers
Journal:  Cell       Date:  2016-06-16       Impact factor: 41.582

9.  A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis.

Authors:  Masayuki Fujii; Mariko Shimokawa; Shoichi Date; Ai Takano; Mami Matano; Kosaku Nanki; Yuki Ohta; Kohta Toshimitsu; Yoshihiro Nakazato; Kenta Kawasaki; Toshio Uraoka; Toshiaki Watanabe; Takanori Kanai; Toshiro Sato
Journal:  Cell Stem Cell       Date:  2016-05-19       Impact factor: 24.633

Review 10.  Adult lung stem cells and their contribution to lung tumourigenesis.

Authors:  Marie-Liesse Asselin-Labat; Caitlin E Filby
Journal:  Open Biol       Date:  2012-08       Impact factor: 6.411

View more
  11 in total

Review 1.  The potential of organoids in toxicologic pathology: Histopathological and immunohistochemical evaluation of a mouse normal tissue-derived organoid-based carcinogenesis model.

Authors:  Rikako Ishigamori; Mie Naruse; Akihiro Hirata; Yoshiaki Maru; Yoshitaka Hippo; Toshio Imai
Journal:  J Toxicol Pathol       Date:  2022-04-22       Impact factor: 1.250

Review 2.  Shortcuts to intestinal carcinogenesis by genetic engineering in organoids.

Authors:  Yoshiaki Maru; Kunishige Onuma; Masako Ochiai; Toshio Imai; Yoshitaka Hippo
Journal:  Cancer Sci       Date:  2019-02-03       Impact factor: 6.716

3.  Establishment and characterization of patient-derived organoids from a young patient with cervical clear cell carcinoma.

Authors:  Yoshiaki Maru; Naotake Tanaka; Keiko Ebisawa; Akiko Odaka; Takahiro Sugiyama; Makiko Itami; Yoshitaka Hippo
Journal:  Cancer Sci       Date:  2019-07-23       Impact factor: 6.716

Review 4.  Current Status of Patient-Derived Ovarian Cancer Models.

Authors:  Yoshiaki Maru; Yoshitaka Hippo
Journal:  Cells       Date:  2019-05-25       Impact factor: 6.600

5.  Cancer inhibition mechanism of lung cancer mouse model based on dye trace method.

Authors:  Wei Zhang; Hongyan Shu; Lixin Fang; Ning Tang; Yucai Li; Bingrong Guo; Fanhui Meng
Journal:  Saudi J Biol Sci       Date:  2020-01-03       Impact factor: 4.219

Review 6.  Where We Stand: Lung Organotypic Living Systems That Emulate Human-Relevant Host-Environment/Pathogen Interactions.

Authors:  Rocio J Jimenez-Valdes; Uryan I Can; Brian F Niemeyer; Kambez H Benam
Journal:  Front Bioeng Biotechnol       Date:  2020-08-13

7.  Precision modeling of gall bladder cancer patients in mice based on orthotopic implantation of organoid-derived tumor buds.

Authors:  Shingo Kato; Kentaro Fushimi; Yuichiro Yabuki; Yoshiaki Maru; Sho Hasegawa; Tetsuya Matsuura; Daisuke Kurotaki; Akihiro Suzuki; Noritoshi Kobayashi; Masato Yoneda; Takuma Higurashi; Makiko Enaka; Tomohiko Tamura; Yoshitaka Hippo; Atsushi Nakajima
Journal:  Oncogenesis       Date:  2021-04-17       Impact factor: 7.485

Review 8.  Recent Advances in Implantation-Based Genetic Modeling of Biliary Carcinogenesis in Mice.

Authors:  Masashi Izumiya; Shingo Kato; Yoshitaka Hippo
Journal:  Cancers (Basel)       Date:  2021-05-11       Impact factor: 6.639

9.  Kras activation in endometrial organoids drives cellular transformation and epithelial-mesenchymal transition.

Authors:  Yoshiaki Maru; Naotake Tanaka; Yasutoshi Tatsumi; Yuki Nakamura; Makiko Itami; Yoshitaka Hippo
Journal:  Oncogenesis       Date:  2021-06-25       Impact factor: 7.485

10.  Establishment and Molecular Phenotyping of Organoids from the Squamocolumnar Junction Region of the Uterine Cervix.

Authors:  Yoshiaki Maru; Akira Kawata; Ayumi Taguchi; Yoshiyuki Ishii; Satoshi Baba; Mayuyo Mori; Takeshi Nagamatsu; Katsutoshi Oda; Iwao Kukimoto; Yutaka Osuga; Tomoyuki Fujii; Yoshitaka Hippo
Journal:  Cancers (Basel)       Date:  2020-03-15       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.